Muhammad Ammar Samad

Mr. Muhammad Ammar Samad

Dow University of Health Sciences, Karachi, Sindh, Pakistan
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
ASAimen Shafiq
Aimen Shafiq
EMEman Mahboob
Eman Mahboob
MSMuhammad Ammar Samad
Muhammad Ammar Samad
MRMohammad Hassam Ur Rehman
Mohammad Hassam Ur Rehman
ZTZoaib Habib Tharwani
Zoaib Habib Tharwani
Empagliflozin (Jardiance®) is an insulin independent antihyperglycemic agent used in treatment of T2D.The drug is a sodium glucose cotransporter-2 (SGLT2) inhibitor approved in USA and Europe and other countries of the world. As empagliflozin demonstrates cardioprotective and Reno protective properties its prime target are patients having CVD and CKD complicated by T2D.

30 June 2022 in Blood Research
Verified
Journal Article
Open access
PDF file
MSMuhammad Ammar Samad
Muhammad Ammar Samad
EMEman Mahboob
Eman Mahboob
HMHussain Mansoor
Hussain Mansoor
Muhammad Ammar Samad, Eman Mahboob, Hussain Mansoor. Blood Res 2022;57:95-100. https://doi.org/10.5045/br.2022.2021173

9 November 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MSMuhammad Ammar Samad
Muhammad Ammar Samad
EMEman Mahboob
Eman Mahboob
ASAimen Shafiq
Aimen Shafiq
MRMohammad Hassam Ur Rehman
Mohammad Hassam Ur Rehman
ASAyesha Sheikh
Ayesha Sheikh
ZTZoaib Habib Tharwani
Zoaib Habib Tharwani
T cell lymphoma, a type of non-Hodgkin lymphomas is a rare form of malignancy with poor outcomes.

5 August 2024 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
MFMuhammad Faizan
Muhammad Faizan
EMEman Mahboob
Eman Mahboob
MSMuhammad Ammar Samad
Muhammad Ammar Samad
LFLeenah Fatima
Leenah Fatima
AFAmmara Fatima
Ammara Fatima
MIMuhammad Hasanain Imran
Muhammad Hasanain Imran